Debating the Role of ALP Normalization in PBC: Curbside Consults Podcast
How should we manage primary biliary cholangitis (PBC) in people with high ALP levels? Listen to learn more about the role of ALP and the biochemical response in PBC management from expert faculty, Dr Stuart Gordon and Dr Nancy Reau, as they discuss an illustrative patient case and explain what to expect from treatment.
Decera Clinical Education Infectious Disease Podcast · Stuart C. Gordon MD, Nancy Reau MD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this podcast, expert faculty, Dr Stuart Gordon and Dr Nancy Reau, use an illustrative patient case to explore the roles of ALP and other biochemical markers in PBC management, and explain what to expect from treatment. Topics covered include:
- How baseline ALP can affect ALP normalization after second-line treatment with elafibranor and seladelpar
- Potential outcomes if ALP normalization cannot be achieved
- The importance of managing fatigue, pruritus, and sleep disturbances independently of the biochemical response
Presenters:
Stuart C. Gordon, MD
Professor of Medicine
Wayne State University School of Medicine
Director, Division of Hepatology
Henry Ford Health
Detroit, Michigan
Nancy Reau, MD
Professor of Medicine
Richard B. Capps Chair of Hepatology
Chief, Section of Hepatology
Associate Director, Solid Organ Transplantation
Rush University Medical Center
Chicago, Illinois
To learn more about PBC management, check out our program,
Curbside Consults: Expert Insights on Challenges in PBC Management.
Supported by educational grants from Gilead Sciences, Inc. and Ipsen Biopharmaceuticals, Inc
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.